Press & Media

Media kit & press resources

For journalists, podcast hosts, and researchers. EBL is an independent evidence-grading platform — no pharmaceutical funding, no supplement company affiliations, no paid editorial content.

What EBL is

Evidence Based Longevity is an independent supplement and device evidence-grading platform. Every product is graded A–D based exclusively on peer-reviewed human RCT data. No animal studies enter a grade. No affiliate revenue changes one.

By the numbers
Supplements graded122
Free tools14
Medications covered50+
Device categories13
Sister siteKosherLongevity.com
Founder
EBL
EBL Founder
Longevity Researcher & Clinical Nutritionist · A4M Diplomate

Founder of Evidence Based Longevity and Kosher Longevity. Clinical background in nutrition and longevity medicine. Diplomate of the American Academy of Anti-Aging Medicine (A4M). Independent — no financial stake in any product, brand, or laboratory on this site.

For interview requests: use the contact form
Institutional associations
American Academy of Anti-Aging Medicine (A4M)
Diplomate · Fellowship in Anti-Aging, Regenerative, and Functional Medicine
Examine.com Concordance
Independent methodology crosswalk — EBL grades mapped to Examine.com grades with divergence explanations View →
Additional associations and citations added here post-licensure
Press mentions & citations
Press coverage added here as it accumulates.
Post-licensure targets: KevinMD · AgingBiotech.info · Lifespan.io · A4M Conference
Key claims for press use
"The only longevity platform that grades supplements A–D based exclusively on peer-reviewed human RCT data — no animal studies, no mechanistic extrapolation."
"Medication-first before supplementing — the drug-nutrient interaction check that most supplement sites skip entirely."
"The only evidence-graded supplement platform with verified kosher certification and halachic guidance — via KosherLongevity.com."
Press & interview enquiries
Response within 48 hours. Available for podcast interviews, expert quotes, and written commentary.
Get in touch →